The problem of Pseudomonas as a nosocomial pathogen is not new, with some authors dating its onset to the start of the antimicrobial era, although other factors, such as the growth of intensive or augmented care, have a part to play. This paper outlines the historical and environmental issues that may be associated with a potential increase in the incidence of this difficult-to-treat pathogen.
No takes yet. Share an insight, caveat, or question.
M.C. Kelsey (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: